
My Chau T. Tran
Examiner (ID: 10784, Phone: (571)272-0810 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1639, 1629, 2629, 1641, 2699 |
| Total Applications | 1249 |
| Issued Applications | 860 |
| Pending Applications | 53 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10975479
[patent_doc_number] => 20140378514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'FUNGICIDE COMPOSITIONS COMPRISING FLUOPYRAM, AT LEAST ONE SUCCINATE DEHYDROGENASE (SDH) INHIBITOR AND OPTIONALLY AT LEAST ONE TRIAZOLE FUNGICIDE'
[patent_app_type] => utility
[patent_app_number] => 14/370655
[patent_app_country] => US
[patent_app_date] => 2013-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21579
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370655 | Fungicide compositions comprising fluopyram, at least one succinate dehydrogenase (SDH) inhibitor and optionally at least one triazole fungicide | Jan 7, 2013 | Issued |
Array
(
[id] => 10057214
[patent_doc_number] => 09096555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Methods for treating vascular leak syndrome'
[patent_app_type] => utility
[patent_app_number] => 13/724396
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 56833
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/724396 | Methods for treating vascular leak syndrome | Dec 20, 2012 | Issued |
Array
(
[id] => 10057214
[patent_doc_number] => 09096555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Methods for treating vascular leak syndrome'
[patent_app_type] => utility
[patent_app_number] => 13/724396
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 56833
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/724396 | Methods for treating vascular leak syndrome | Dec 20, 2012 | Issued |
Array
(
[id] => 10947080
[patent_doc_number] => 20140350101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'GEL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/364364
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13211
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364364
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/364364 | GEL COMPOSITIONS | Dec 11, 2012 | Abandoned |
Array
(
[id] => 8766136
[patent_doc_number] => 20130094173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Display Device And An Electronic Apparatus Using The Same'
[patent_app_type] => utility
[patent_app_number] => 13/707647
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9338
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707647 | Display device and an electronic apparatus using the same | Dec 6, 2012 | Issued |
Array
(
[id] => 10234463
[patent_doc_number] => 20150119457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY'
[patent_app_type] => utility
[patent_app_number] => 14/380999
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3083
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380999
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/380999 | ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY | Nov 8, 2012 | Abandoned |
Array
(
[id] => 8822178
[patent_doc_number] => 20130123223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => '4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/673623
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7252
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673623
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673623 | 4-pregenen-11β-17-21-triol-3,20-dione derivatives | Nov 8, 2012 | Issued |
Array
(
[id] => 8904904
[patent_doc_number] => 20130172407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide'
[patent_app_type] => utility
[patent_app_number] => 13/669637
[patent_app_country] => US
[patent_app_date] => 2012-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5385
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13669637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/669637 | Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide | Nov 5, 2012 | Abandoned |
Array
(
[id] => 8792749
[patent_doc_number] => 20130109718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => '1-CYCLOALKYL- OR 1-HETEROCYCLYL-HYDROXYIMINO-3-PHENYL-PROPANES'
[patent_app_type] => utility
[patent_app_number] => 13/658878
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24205
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658878
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/658878 | 1-CYCLOALKYL- OR 1-HETEROCYCLYL-HYDROXYIMINO-3-PHENYL-PROPANES | Oct 23, 2012 | Abandoned |
Array
(
[id] => 8792782
[patent_doc_number] => 20130109751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'LSD-1 ENZYME INHIBITORS FOR INDUCING OSTEOGENIC DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 13/659167
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2047
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13659167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/659167 | LSD-1 ENZYME INHIBITORS FOR INDUCING OSTEOGENIC DIFFERENTIATION | Oct 23, 2012 | Abandoned |
Array
(
[id] => 11828711
[patent_doc_number] => 09725442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Heterocyclic derivative having PGD2 receptor antagonist activity'
[patent_app_type] => utility
[patent_app_number] => 14/351234
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90404
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351234
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351234 | Heterocyclic derivative having PGD2 receptor antagonist activity | Oct 23, 2012 | Issued |
Array
(
[id] => 9786446
[patent_doc_number] => 20140303266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'METHODS OF PREPARATION AND FORMING SUPPORTED ACTIVE METAL CATALYSTS AND PRECURSORS'
[patent_app_type] => utility
[patent_app_number] => 14/351920
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14754
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351920 | Methods of preparation and forming supported active metal catalysts and precursors | Oct 21, 2012 | Issued |
Array
(
[id] => 10911740
[patent_doc_number] => 20140314757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/352390
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 7132
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352390 | PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF BREAST CANCER | Oct 16, 2012 | Abandoned |
Array
(
[id] => 9422574
[patent_doc_number] => 20140107225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'THERAPEUTIC APPLICATION OF CEMBRANOIDS AGAINST HIV VIRUS REPLICATION, HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS AND HIV VIRUS-INDUCED INFLAMMATION.'
[patent_app_type] => utility
[patent_app_number] => 13/649828
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3117
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13649828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/649828 | Therapeutic application of cembranoids against HIV virus replication, HIV-associated neurocognitive disorders and HIV virus-induced inflammation | Oct 10, 2012 | Issued |
Array
(
[id] => 9757390
[patent_doc_number] => 20140288091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'MONO-FLUORO BETA-SECRETASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/350729
[patent_app_country] => US
[patent_app_date] => 2012-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23324
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350729
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350729 | Mono-fluoro beta-secretase inhibitors | Oct 9, 2012 | Issued |
Array
(
[id] => 10620616
[patent_doc_number] => 09339543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Pharmaceutical compositions that inhibit disproportionation'
[patent_app_type] => utility
[patent_app_number] => 14/350839
[patent_app_country] => US
[patent_app_date] => 2012-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7474
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350839
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350839 | Pharmaceutical compositions that inhibit disproportionation | Oct 7, 2012 | Issued |
Array
(
[id] => 11749198
[patent_doc_number] => 09707196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Treatment agent and/or prophylactic agent for side effects of cancer drugs'
[patent_app_type] => utility
[patent_app_number] => 14/350520
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7768
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350520 | Treatment agent and/or prophylactic agent for side effects of cancer drugs | Oct 4, 2012 | Issued |
Array
(
[id] => 11243565
[patent_doc_number] => 09469598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Erythropoietin production-promoting agent'
[patent_app_type] => utility
[patent_app_number] => 14/350522
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4684
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350522
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350522 | Erythropoietin production-promoting agent | Oct 4, 2012 | Issued |
Array
(
[id] => 11798507
[patent_doc_number] => 09539225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Anemia of cancer improving/prophylactic agent'
[patent_app_type] => utility
[patent_app_number] => 14/350675
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5046
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350675
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350675 | Anemia of cancer improving/prophylactic agent | Oct 4, 2012 | Issued |
Array
(
[id] => 11250264
[patent_doc_number] => 09475755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Prophylactic agent for chronic kidney disease'
[patent_app_type] => utility
[patent_app_number] => 14/350526
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4897
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350526 | Prophylactic agent for chronic kidney disease | Oct 4, 2012 | Issued |